跳至主要内容
临床试验/ACTRN12621000889853
ACTRN12621000889853进行中(未招募)未知

Effect on glycaemic outcomes in people with type 2 diabetes initiating continuous glucose monitoring: The 2GO-CGM study

niversity of Otago0 个研究点目标入组 71 人开始时间: 2021年7月8日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
71

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • 1.Type 2 diabetes as per ADA classification
  • 2.HbA1c greater than 8.0%
  • 3.Minimum daily insulin requirement of greater than or equal to 0.2 units insulin/kg/day, for at least 3 months previous to study enrollment.
  • 4.Aged 16 years and over.
  • 5.Be willing and able to conform to the study protocol

排除标准

  • 1.History of Type 1 diabetes
  • 2.History of other types of diabetes such as MODY, secondary pancreatic diabetes, diabetes due to endocrinopathies
  • 3.Has had a hospital admission for hyperglycaemia in last 6 months
  • 4.Use of systemic corticosteroids for more than 14 days, or repeated pharmacologic systemic courses of corticosteroids
  • 5.Recurrent or chronic systemic infections that in the view of the investigator would significantly impact on glycaemia.
  • 6.Major cardiovascular event (including or not limited to MI, CVA, CABG, PTCA) or major surgery in last 3 months
  • 7.Active malignancy requiring ongoing treatment
  • 8.Previous or planned bariatric surgery.
  • 9.Pregnancy
  • 10.Any other reason that investigator feels may not be in best interest of patient to participate.

研究者

相似试验